**Core Concept**
Osteogenesis imperfecta (OI) is a genetic disorder characterized by the production of defective collagen, leading to fragile bones and other systemic manifestations.

**Why the Correct Answer is Right**
The characteristic findings in OI are due to mutations in the COL1A1 and COL1A2 genes, which code for the alpha-1 and alpha-2 chains of type I collagen. The defective collagen leads to impaired bone mineralization, resulting in blue sclerae, tooth translucency, and bone fragility. The increased susceptibility to fractures is a hallmark of the disease.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as it does not describe any known genetic disorder with characteristic findings of blue sclerae, tooth translucency, and bone fragility.

**Option B:** This option is incorrect as it does not match the clinical presentation of OI.

**Option C:** This option is incorrect as it does not describe any known genetic disorder with characteristic findings of blue sclerae, tooth translucency, and bone fragility.

**Option D:** This option is incorrect as it does not match the clinical presentation of OI.

**Clinical Pearl / High-Yield Fact**
Osteogenesis imperfecta is often referred to as "brittle bone disease" due to its characteristic susceptibility to fractures. It is essential to consider this diagnosis in patients with a history of recurrent fractures, particularly in the context of other systemic manifestations.

**Correct Answer:** . Osteogenesis imperfecta.